brain plasma amyloid-beta efflux: measure brain amyloid burden mouse model alzheimers disease 
deposition amyloid-beta abeta peptides amyloid plaques precedes cognitive dysfunction alzheimers disease ad years biomarkers indicative brain amyloid burden useful identifying individuals high risk developing ad ad humans baseline plasma abeta levels transgenic mouse model ad correlate brain amyloid burden however peripheral administration monoclonal antibody abeta m266 observed rapid increase plasma abeta magnitude increase highly correlated amyloid burden hippocampus cortex method may useful quantifying brain amyloid burden patients risk diagnosed ad 
